Table 4 Scheme of scheduled visits. At T0 blood and stool samples will be collected from 1000 women, urine samples from 5200 women. At T1 capillary blood will be collected from 5200 women. At T2 no biological samples will be collected. At T3 and T4 capillary blood will be collected from all the women attending the follow-up visit, urine will be collected from all the participants attending the follow-up visit. Considering the loss to follow up 4472 mothers and 4472 children are expected at T3 to remain in the study and 3900 women and 3900 children at 4. UCP-CF (Up-Converting Phosphor – Consecutive Flow) antibody assay will be performed on serum samples. Hb will be measured on capillary blood. UCP-LF-CAA (Up-Converting Phosphor – Lateral Flow) and POC-CCA will be performed on urine samples. PCR will be performed on urine, plasma and stool samples. Microscopy will be performed on stool samples
